Structural basis of nucleic-acid recognition and double-strand unwinding by the essential neuronal protein Pur-alpha

  1. Janine Weber
  2. Han Bao
  3. Christoph Hartlmüller
  4. Zhiqin Wang
  5. Almut Windhager
  6. Robert Janowski
  7. Tobias Madl
  8. Peng Jin
  9. Dierk Niessing  Is a corresponding author
  1. Helmholtz Zentrum München - German research center for environmental health, Germany
  2. Emory University, United States
  3. Technische Universität München, Germany

Abstract

The neuronal DNA-/RNA-binding protein Pur-alpha is a transcription regulator and core factor for mRNA-localization. Pur-alpha deficient mice die after birth with pleiotropic neuronal defects. Here we report the crystal structure of the DNA-/RNA-binding domain of Pur-alpha in complex with ssDNA. It reveals base-specific recognition and offers a molecular explanation for the effect of point mutations in the 5q31.3 microdeletion syndrome. Consistent with the crystal structure, biochemical and NMR data indicate that Pur-alpha binds DNA and RNA in the same way, suggesting binding modes for tri- and hexanucleotide repeat RNAs in two neurodegenerative RNAopathies. Additionally, structure-based in vitro experiments resolved the molecular mechanism of Pur-alpha's unwindase activity. Complementing in vivo analyses in Drosophila demonstrated the importance of a highly conserved phenylalanine for Pur-alpha's unwinding and neuroprotective function. By uncovering the molecular mechanisms of nucleic-acid binding, this study contributes to understanding the cellular role of Pur-alpha and its implications in neurodegenerative diseases.

Article and author information

Author details

  1. Janine Weber

    Institute of Structural Biology, Helmholtz Zentrum München - German research center for environmental health, Neuherberg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  2. Han Bao

    Department of Human Genetics, Emory University, Atlanta, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Christoph Hartlmüller

    Center for Integrated Protein Science Munich, Department of Chemistry, Technische Universität München, Munich, Germany
    Competing interests
    The authors declare that no competing interests exist.
  4. Zhiqin Wang

    Department of Human Genetics, Emory University, Atlanta, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Almut Windhager

    Institute of Structural Biology, Helmholtz Zentrum München - German research center for environmental health, Neuherberg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  6. Robert Janowski

    Institute of Structural Biology, Helmholtz Zentrum München - German research center for environmental health, Neuherberg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  7. Tobias Madl

    Institute of Structural Biology, Helmholtz Zentrum München - German research center for environmental health, Neuherberg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  8. Peng Jin

    Department of Human Genetics, Emory University, Atlanta, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Dierk Niessing

    Institute of Structural Biology, Helmholtz Zentrum München - German research center for environmental health, Neuherberg, Germany
    For correspondence
    dierk.niessing@med.uni-muenchen.de
    Competing interests
    The authors declare that no competing interests exist.

Reviewing Editor

  1. Karsten Weis, ETH Zürich, Switzerland

Version history

  1. Received: September 3, 2015
  2. Accepted: January 7, 2016
  3. Accepted Manuscript published: January 8, 2016 (version 1)
  4. Accepted Manuscript updated: January 12, 2016 (version 2)
  5. Version of Record published: February 11, 2016 (version 3)

Copyright

© 2016, Weber et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,235
    views
  • 443
    downloads
  • 33
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Janine Weber
  2. Han Bao
  3. Christoph Hartlmüller
  4. Zhiqin Wang
  5. Almut Windhager
  6. Robert Janowski
  7. Tobias Madl
  8. Peng Jin
  9. Dierk Niessing
(2016)
Structural basis of nucleic-acid recognition and double-strand unwinding by the essential neuronal protein Pur-alpha
eLife 5:e11297.
https://doi.org/10.7554/eLife.11297

Share this article

https://doi.org/10.7554/eLife.11297

Further reading

    1. Biochemistry and Chemical Biology
    2. Microbiology and Infectious Disease
    Natalia E Ketaren, Fred D Mast ... John D Aitchison
    Research Advance

    To date, all major modes of monoclonal antibody therapy targeting SARS-CoV-2 have lost significant efficacy against the latest circulating variants. As SARS-CoV-2 omicron sublineages account for over 90% of COVID-19 infections, evasion of immune responses generated by vaccination or exposure to previous variants poses a significant challenge. A compelling new therapeutic strategy against SARS-CoV-2 is that of single-domain antibodies, termed nanobodies, which address certain limitations of monoclonal antibodies. Here, we demonstrate that our high-affinity nanobody repertoire, generated against wild-type SARS-CoV-2 spike protein (Mast et al., 2021), remains effective against variants of concern, including omicron BA.4/BA.5; a subset is predicted to counter resistance in emerging XBB and BQ.1.1 sublineages. Furthermore, we reveal the synergistic potential of nanobody cocktails in neutralizing emerging variants. Our study highlights the power of nanobody technology as a versatile therapeutic and diagnostic tool to combat rapidly evolving infectious diseases such as SARS-CoV-2.

    1. Biochemistry and Chemical Biology
    Benjamin R Duewell, Naomi E Wilson ... Scott D Hansen
    Research Article

    Phosphoinositide 3-kinase (PI3K) beta (PI3Kβ) is functionally unique in the ability to integrate signals derived from receptor tyrosine kinases (RTKs), G-protein coupled receptors, and Rho-family GTPases. The mechanism by which PI3Kβ prioritizes interactions with various membrane-tethered signaling inputs, however, remains unclear. Previous experiments did not determine whether interactions with membrane-tethered proteins primarily control PI3Kβ localization versus directly modulate lipid kinase activity. To address this gap in our knowledge, we established an assay to directly visualize how three distinct protein interactions regulate PI3Kβ when presented to the kinase in a biologically relevant configuration on supported lipid bilayers. Using single molecule Total Internal Reflection Fluorescence (TIRF) Microscopy, we determined the mechanism controlling PI3Kβ membrane localization, prioritization of signaling inputs, and lipid kinase activation. We find that auto-inhibited PI3Kβ prioritizes interactions with RTK-derived tyrosine phosphorylated (pY) peptides before engaging either GβGγ or Rac1(GTP). Although pY peptides strongly localize PI3Kβ to membranes, stimulation of lipid kinase activity is modest. In the presence of either pY/GβGγ or pY/Rac1(GTP), PI3Kβ activity is dramatically enhanced beyond what can be explained by simply increasing membrane localization. Instead, PI3Kβ is synergistically activated by pY/GβGγ and pY/Rac1 (GTP) through a mechanism consistent with allosteric regulation.